The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015-Reference-Cited by-同舟云学术

The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

Published:2012-04 Issue:6 Volume:87 Page:504-510
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Farkas Szabolcs,Nagy Katalin,Jia Zhisheng,Harkany Tibor,Palkovits Miklós,Donohou Sean R.,Pike Victor W.,Halldin Christer,Máthé Domokos,Csiba László,Gulyás Balázs

Publisher

Elsevier BV

Subject

General Neuroscience

Reference106 articles.

1. Change in brain dopamine receptor in MPTP parkinsonian monkeys following L-DOPA treatment;Alexander;Brain Res.,1993

2. The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway;Anderson;Brain Res.,1995

3. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride;Antonini;Mov. Disord.,1997

4. Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration;Barbier;J. Neural Transm.,1997

5. Calibration of [14C] plastic standards for quantitative autoradiography of [125I] labeled ligands with Amersham Hyperfilm β-max;Baskin;Neurosci. Lett.,1989

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders;Basic & Clinical Pharmacology & Toxicology;2024-03-13

2. Time-Course of Alterations in the Endocannabinoid System after Viral-Mediated Overexpression of α-Synuclein in the Rat Brain;Molecules;2022-01-14

3. Parkinson’s disease related alterations in cannabinoid transmission;Brain Research Bulletin;2022-01

4. Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson’s disease in rats: Possible role of endocannabinoid system modulation;International Immunopharmacology;2021-05

5. Dopaminergic denervation impairs cortical motor and associative/limbic information processing through the basal ganglia and its modulation by the CB1 receptor;Neurobiology of Disease;2021-01